Please use this identifier to cite or link to this item:
|Title:||Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes|
|Citation:||Selvin, E., Ning, Y., Steffes, M.W., Bash, L.D., Klein, R., Wong, T.Y., Astor, B.C., Sharrett, A.R., Brancati, F.L., Coresh, J. (2011-01). Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 60 (1) : 298-305. ScholarBank@NUS Repository. https://doi.org/10.2337/db10-1198|
|Abstract:||OBJECTIVE: Glycated hemoglobin was recently recommended for use as a diagnostic test for diabetes. We examined the association between 2010 American Diabetes Association diagnostic cut points for glycated hemoglobin and microvascular outcomes (chronic kidney disease, end-stage renal disease [ESRD], and retinopathy) and formally tested for the presence of risk thresholds in the relationships of glycated hemoglobin with these outcomes. RESEARCH DESIGN AND METHODS: Prospective cohort and cross-sectional analyses of 11,357 participants (773 with a history of diagnosed diabetes) from the Atherosclerosis Risk in Communities (ARIC) Study. RESULTS: During a median of 14 years of follow-up of individuals without diagnosed diabetes at baseline, clinical categories of glycated hemoglobin were associated with risk of chronic kidney disease, with adjusted hazard ratios (HRs) of 1.12 (0.94 -1.34) and 1.39 (1.04 -1.85) for glycated hemoglobin 5.7- 6.4% and|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Sep 22, 2018
WEB OF SCIENCETM
checked on Sep 12, 2018
checked on Sep 21, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.